Concepedia

Kathy L. McGraw

KL

38

Publications

3.2K

Citations

28

H-Index

1997

Active since

Affiliations

Moffitt Cancer Center(Current)

University of South Florida

Cleveland Clinic

Groupe Francophone des Myélodysplasies

Dana-Farber Cancer Institute

Kathy L. McGraw is an author at Moffitt Cancer Center specializing in medicine, hematology, and cell biology.

ORCID

Top concepts

Publications per year

1997–2022

38

Publications

38

Eprenetapopt (APR-246) and Azacitidine in <i>TP53</i>-Mutant Myelodysplastic Syndromes

David A. Sallman, Amy E. DeZern, Guillermo Garcia‐Manero et al. · Journal of Clinical Oncology · 2021 · 436 citations · Full text

STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

Andrés Jerez, Michael J. Clemente, Hideki Makishima et al. · Blood · 2012 · 408 citations · Full text

The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype

Ashley A. Basiorka, Kathy L. McGraw, Erika A. Eksioglu et al. · Blood · 2016 · 337 citations · Full text

Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes

David A. Sallman, Rami S. Komrokji, Christine Vaupel et al. · Leukemia · 2015 · 226 citations · Full text

, , +6

<i>TP53</i> mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype

David A. Sallman, Amy F. McLemore, Amy L. Aldrich et al. · Blood · 2020 · 177 citations · Full text

Rows per page

1–5 of 38